http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109180784-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
filingDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109180784-B
titleOfInvention A kind of bursa of farbricius activity hexapeptide and application promoting bird flu and/or the immune response of newcastle disease vaccine
abstract It identifies and applies the present invention relates to a kind of promotion bird flu and/or with the separation of the bursa of farbricius activity hexapeptide of the immune response of newcastle disease bigeminy vaccine.Bursa of farbricius activity hexapeptide of the present invention, amino acid group become Lys Gly Asn Arg Val Tyr, and structure is simple, and immunogenicity is extremely weak.Active peptide of the present invention has the function of promoting vaccine immunity reaction, in mouse immune experiment, not only mouse is promoted to generate the antibody response for being directed to AIV antigen, and mouse is promoted to generate the antibody response for being directed to ndv antigen, furthermore, also promote cell immune response, the enhancing of lymphocyte vigor, the reaction of antigen submission and raising vaccine immunity effect effect, it can be used as vaccine adjuvant or immunopotentiator be applied to animal vaccine application study, to improve the immune response ability that animal body is directed to specific antigen, improve the immune efficacy of vaccine, to improve the ability of the anti-epidemic disease infection of animal body.
priorityDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID2560319
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9835593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID194104
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426130833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415871727
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID358014
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2560319
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7022320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426384047
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID358014

Total number of triples: 41.